簡(jiǎn)體中文
English
日本語(yǔ)
???
Headquarter:
Add: Jiangxi Fengxin Industrial Park, Fengxin,Jiangxi,P.R.China
Tel: +86-795-4605771,4605608
Fax: +86-795-4605772
E-mail: info@jxsynergy.com
Post Code: 330700
Sales Center:
Room 1901, Tower A, Yuanshen Financial Building, NO. 355 Yuanshen Road, Pudong New Area, Shanghai China
Tel:+86-21-62886322
E-mail: sales@jxsynergy.com
Post Code: 200135
Products
| Code | Product Name | CAS No. |
| Rivaroxaban | ||
| MLT | 4-(4-Aminophenyl)morpholin-3-one | 438056-69-0 |
| HBY | (S)-(+)- Glycidyl Phthalimide | 161596-47-0 |
| Apixaban | ||
| APX-YJZ | 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester | 27143-07-3 |
| APX-BDT | 5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone | 545445-44-1 |
| Empagliflozin | ||
| ETHF-1 | (5-bromo-2-chlorophenyl)(4-fluorophenyl)methanone | 915095-85-1 |
| EMPZ N-1 | Acetyl Empagliflozin | 915095-99-7 |
| Canagliflozin | ||
| CGBR | 2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl]thiophene | 1030825-20-7 |
| Ipragliflozin | ||
| IGLZ-1 | 1-benzothien-2-yl(5-bromo-2-fluorophenyl)methanol | 1034305-11-7 |
| IGLZ-3 | 2-(5-BroMo-2-fluorobenzyl)benzo[b]thiophene | 1034305-17-3 |
| Mirabegron | ||
| MBL-2 | (R)-2-(4-nitrophenethylamino)-1-phenylethanol | 223673-34-5 |
| MBL-3 | (R)-2-((4-aminophenethyl)amino)-1-phenylethan-1-ol | 391901-45-4 |
| Vibegron | ||
| VIBG-11 | (R)-((2R,5S)-5-(4-aminobenzyl)pyrrolidin-2-yl)(phenyl)methanol | 1295539-30-8 |
| VIBG-M2 | Sodium(S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate | 1421271-01-3 |
| Agomelatine | ||
| MO | 7-Methoxy-1-Tetralone | 6836-19-7 |
| AG-3 | (7-methoxy-1-naphthyl) acetonitrile | 138113-08-3 |
| Febuxostat | ||
| FBXT-5 | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | 160844-75-7 |
| Vildagliptin | ||
| VGLT-S1 | L-Prolinamide | 7531-52-4 |
| Vonoprazan Fumarate | ||
| VOPZ-4 | 5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile | 1240948-77-9 |
| VOPZ-6 | 5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrole-3-carboxaldehyde | 881677-11-8 |
| Dabigatran Etexilate Mesylate | ||
| DBG-3 | 3-[(3-amino-4-methylamino-benzoyl)pyridine-2-yl-amino]propionic acid ethyl ester | 212322-56-0 |
| NGC | N-(4-Cyano-phenyl)-glycine | 42288-26-6 |
| DBG-4 | Alanine,N-[[2-[[(4-cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester | 211915-84-3 |
| DBG-5 | Alanine,N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, monohydrochloride | 211914-50-0 |
| Azilsartan Base & Medoxomil Potassium | ||
| CDS-7 | Methyl-1[(2’cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate | 139481-44-0 |
| AZST-1 | 2-ethoxy-1-((2'-((hydroxyamino)iminomethyl)(1,1'-biphenyl)-4-yl)methyl)-1h-benzimidazole-7-carboxylic acid methyl ester | 147403-65-4 |
| Candesartan Cilexetil | ||
| TCDS | Trityl Candesartan | 139481-72-4 |
| Rimegepant | ||
| RMGP-5 | (R)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-onehydrochloride | 1190363-45-1 |
| RMGP-6 | (6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-9-[[tris(1-methylethyl)silyl]oxy]-5H-cyclohepta[b]pyridin-5-one | 1190363-46-2 |
| RMGP-7 | (5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-aminedihydrochloride | 1373116-04-1 |
| Resmetirom | ||
| RSTL-3 | 6-(4-amino-2,6-dichlorophenoxy)-2,3-dihydropyridazin-3-one | N/A |
| RSTL-4 | 6-(4-amino-2,6-dichlorophenoxy)-4-(propan-2-yl)-2,3-dihydropyridazin-3-one | 920509-28-0 |
| RSTL-5 | ethyl N-[(E)-cyano[2-(3,5-dichloro-4-{[6-oxo-5-(propan-2-yl)-1,6-di-hydro-pyridazin-3-yl]oxy}phenyl)hydrazin-1-ylidene]carbonyl]carbamate | 920509-33-7 |
| Opicapone | ||
| OPCP-A2 | 3,4-dimethoxy-5-nitrobenzoic acid (innovative process) | 91004-48-7 |
| OPCP-B3 | 2,5-dichloro-4,6-dimethylnicotinonitrile | 91591-63-8 |
| OPCP-B4 | 2,5-dichloro-N'-hydroxy-4,6-dimethylnicotinimidamide | 896125-90-9 |
| OPCP-1 | 2,5-dichloro-3-[5-(3,4-dimethoxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl]-4,6-dimethylpyridine (innovative process) | 2356241-50-2 |
